Human T-lymphoblastic Leukemia (TLL)

T-lymphoblastic leukemia/lymphoma; J.gamma1.WT; Jurkat; A3; HuT 78; 6T-CEM; P116

  • Human T-lymphoblastic Leukemia (TLL) Packages (Simulation)
  • Human T-lymphoblastic Leukemia (TLL) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Biosafety of the Human T-lymphoblastic Leukemia (TLL)

Human T-lymphoblastic Leukemia (TLL) are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi.

Cluture Conditions of the Human T-lymphoblastic Leukemia (TLL)

RPMI-1640+10%FBS+1%Penicillin-Streptomycin Solution. Temperature: 37℃

Product Format of the Human T-lymphoblastic Leukemia (TLL)

Frozen 1 mL or T25 flask.

USAGE of the Human T-lymphoblastic Leukemia (TLL)

Upon receiving the cells in a T-25 flask at room temperature, immediately transfer the cells to 37°C, 5% incubator; the cells in vials, directly and immediately transfer the cells from dry ice to liquid nitrogen.

GIVEAWAYS

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
CSI185Hu11 Human T-lymphoblastic Leukemia (TLL) Jurkat Clone E6-1 (cell line is a suitable transfection host
CSI185Hu12 Human T-lymphoblastic Leukemia (TLL) A3 cell line is used for scientific research
GUESTBOOK